Erratum: Promotion of non-small cell lung cancer tumor growth by FHL2 via inducing angiogenesis and vascular permeability

Erratum to: J Thorac Dis 2024;16:1424-37.

In the article (1) entitled “Promotion of non-small cell lung cancer tumor growth by FHL2 via inducing angiogenesis and vascular permeability”, the panels of Figure 2E (H226 Flag-FHL2) and Figure 2F (H226 siNC), Figure 3C (H226 Flag-FHL2-CM 24h) and Figure 4G (A549 Flag-FHL2-CM 24h), Figure 3D (A549 siNC-CM 24h) and Figure 3D (A549 siFHL2 #1-CM 24h) were duplicated accidently. The figure legend of Figure 2F also contains a spelling mistake.

Figure 2E and 2F of the original article:

Figure 3C and 4G of the original article:

Figure 3D of the original article:

The correct version of Figure 2F (H226 siNC), Figure 3C (H226 Flag-FHL2-CM 24h) and Figure 3D (A549 siNC-CM 24h), figure legend of Figure 2F, containing the correct data are shown below.

Figure 2 FHL2 promoted proliferation of NSCLC cells in vitro. (A) FHL2 protein expression upon transfection with Flag-FHL2 plasmids. (B) FHL2 protein expression upon transfection with siRNA targeting FHL2. (C) CCK-8 assay for investigating FHL2 overexpression effects on the proliferation of A549 and H226 cells. (D) CCK-8 assay for investigating FHL2 silencing effects on the proliferation of A549 and H226 cells. (E) EdU assay for evaluation of FHL2 overexpression effects on the proliferation of A549 and H226 cells (magnification ×100). (F) EdU assay for evaluation of FHL2 silencing effects on the proliferation of A549 and H226 cells (magnification ×100). The independent assays were replicated three times. Mean “±” SD are provided. *, P<0.05; **, P<0.01; ***, P<0.001. FHL2, four-and-a-half LIM-domain protein 2; NSCLC, non-small cell lung cancer; CCK-8, Cell Counting Kit-8; SD, standard deviation.

The authors confirmed these errors did not affect either the results or the conclusions of the paper.

Click here to view the updated version of the article.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

References

1. Chen T, Chen J, Chen Q, et al. Promotion of non-small cell lung cancer tumor growth by FHL2 via inducing angiogenesis and vascular permeability. J Thorac Dis 2024;16:1424-37. [Crossref] [PubMed]